Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells

Journal of Membrane Biology

Volumn 205, Issue 3, 2005, Pages 139-145

  Ise, T ^b   Shimizu, T ^a   Lee, E L ^a   Inoue, H ^a   Kohno, K ^b   Okada, Y ^a  

^a NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Apoptosis; Cancer cell; Cisplatin; Cl channel

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; CASPASE 3; CHLORIDE ION; CISPLATIN; ION CHANNEL;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL FUNCTION; CELL STRAIN KB; CELL SWELLING; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; EXPOSURE; HUMAN; HUMAN CELL; OSMOSIS; PATCH CLAMP; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; WHOLE CELL;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; 4-ACETAMIDO-4'-ISOTHIOCYANATOSTILBENE-2,2'-DISULFONIC ACID; APOPTOSIS; CHLORIDE CHANNELS; CISPLATIN; HUMANS; KB CELLS; PHLORETIN;

EID: 29144449807     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-005-0779-y     Document Type: Article

References (36)

1. Barry, M.A., Behnke, A., Eastman, A. 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40:2353-2362
2. Chu, G. 1994. Cellular responses to cisplatin. The roles of DNA binding proteins and DNA repair. J. Biol. Chem. 269:787-790
3. Cummings, B.S., Schnellmann, R.G. 2002. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J. Pharmacol. Exp. Ther. 302:8-17
4. Deschesnes, R.G., Huot, J., Valerie, K., Landry, J. 2001. Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol. Biol. Cell 12:1569-1582
5. Eastman, A. 1990. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2:275-280
6. - channels. Br. J. Pharmacol. 133:1096-1106
7. Fujii, R., Mutoh, M., Niwa, K., Yamada, K., Aikou, T., Nakagawa, M., Kuwano, M., Akiyama, S. 1994. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn. J. Cancer Res. 85:426-433
8. Jamieson, E.R., Lippard, S.J. 1999. Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99:2467-2498
9. Kharbanda, S., Ren, R., Pandey, P., Shafman, T.D., Feller, S.M., Weichselbaum, R., Kule, D. 1995. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376:785-788
10. Kharbanda, S., Yuan, Z.M., Weichselbaum, R., Kufe, D. 1998. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17:3309-3318
11. Kharbanda, S., Pandey, P., Yamauchi, T., Kumar, S., Kaneki, M., Kumar, V., Bharti, A., Yuan, Z.M., Ghanem, L., Rana, A., Weichselbaum, R., Johnson, G., Kufe, D. 2000. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol. Cell. Biol. 20:4979-4989
12. - channel currents in cultured human epithelial cells. J. Physiol. 456:351-371
13. Laurencot, C.M., Kennedy, K.A. 1995. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells. Oncol Res. 7:371-379
14. Loehrer, P.J., Einhorn, L.H. 1984. Drugs five years later. Cisplatin. Ann. Intern. Med. 100:704-713
15. Maeno, E., Ishizaki, Y., Kanaseki, T., Hazama, A., Okada, Y. 2000. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. USA 97:9487-9492
16. Matsuo, K., Khono, K., Takano, H., Sato, S., Kiue, A., Kuwano, M. 1990. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines. Cancer Res. 50:5819-5824
17. Miller, S.E., House, D.A. 1990. The hydrolysis products of cis-dichlorodiammineplatinum (II). 3. Hydrolysis kinetics at physiological pH. Inorg. Chim. Acta 173:53-60
18. - channel: fresh start to the molecular identity and volume sensor. Am. J. Physiol. 273:C755-C789
19. Okada, Y., Maeno, E., Shimizu, T., Dezaki, K., Wang, J., Morishima, S. 2001. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J. Physiol. 532:3-16
20. Pandey, P., Raingeaud, J., Kaneki, M., Weichselbaum, R., Davis, R.J., Kufe, D., Kharbanda, S. 1996. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms. J. Biol. Chem. 271:23775-23779
21. Persons, D.L., Yazlovitskaya, E.M., Cui, W., Pelling, J.C. 1999. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5:1007-1014
22. Ravi, R., Somani, S.M., Rybak, L.P. 1995. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76:386-394
23. Sanchez-Prieto, R., Rojas, J.M., Taya, Y., Gutkind, J.S. 2000. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60:2464-2472
24. Sanchez-Perez, I., Perona, R. 1999. Lack of c-Jun activity increases survival to cisplatin. FEBS lett. 453:151-158
25. Sanchez-Perez, I., Martinez-Gomariz, M., William, S.D., Keyse, S.M., Perona, R. 2000. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 19:5142-5152
26. - channels in human epithelial cells. J. Physiol. 528:457-472
27. - channel. Proc. Natl. Acad. Sci. USA 101:6770-6773
28. Sklar, M.D., Prochownik, E.V. 1991. Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. Cancer Res. 51:2118-2123
29. Sorenson, C.M., Barry, M.A., Eastman, A. 1990. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 82:749-755
30. Thornberry, N.A. 1994. Interleukin-1 beta converting enzyme. Methods Enzymol. 244:615-631
31. Tsuruya, K., Tokumoto, M., Ninomiya, T., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Hirakata, H., Iida, M. 2003. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am. J. Physiol. 285:F208-F218
32. 2 production in cisplatin-induced nephrotoxicity. Biochem. Biophys. Res. Commun. 242:310-312
33. Wang, X., Martindale, J.L., Holbrook, N.J. 2000. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275:39435-39443
34. Worrell, R.T., Butt, A.G., Cliff, W.H., Frizzell, R.A. 1989. A volume-sensitive chloride conductance in human colonic cell line T84. Am. J. Physiol. 256:C1111-C1119
35. Yarbrough, J.W., Merryman, J.I., Barnhill, M.A., Hahn, K.A. 1999. Inhibitors of intracellular chloride regulation induce cisplatin resistance in canine osteosarcoma cells. In Vivo 13:375-384
36. Yoshida, K., Weichselbaum, R., Kharbanda, S., Kufe, D. 2000. Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage. Mol Cell. Biol. 20:5370-5380